Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II PK/PD Driven Dose Finding Trial of Praziquantel in Children Under Four

NCT03640377 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT03640377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03640377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II PK/PD Driven Dose Finding Trial of Praziquantel in Children Under Four
Lead sponsor
Rhode Island Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2021
Completion date
June 1, 2024
Enrollment
354 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schistosoma japonicum infection, schistosomiasis, schistosomiasis mansoni